ESR1 and neoplasm: These historical milestones illustrate a progression from observational pathology to precise mechanistic understanding and targeted therapy, establishing ER+ bone metastasis as a biologically distinct entity shaped by hormone signaling, tumor–bone crosstalk, and niche-driven evolution.